Pharmacists Poised as Critical Frontline for Upcoming Respiratory Season

As the fall respiratory virus season approaches, pharmacists are being urged to embrace their evolving role as essential public health advocates, educators, and providers.

According to industry expert Angela Haskell, PharmD, BCPS, BCIDP, infectious diseases clinical pharmacy specialist at The Christ Hospital in Cincinnati, the pharmacy serves as a vital “one-stop shop” where patients can safely and effectively receive coadministered vaccines for influenza, COVID-19, and RSV during a single visit. This level of convenience not only improves community adherence but also allows pharmacists to utilize patient data and identify eligible individuals while avoiding missed opportunities for preventative care.

Haskell emphasizes that addressing persistent vaccine hesitancy requires a clinical strategy rooted in trust rather than persuasion. By listening to parental concerns regarding side effects and the necessity of vaccines for healthy children, pharmacists can provide evidence-based information in a respectful, approachable manner.

It is also essential for pharmacists to distinguish between expected immune responses, such as temporary soreness or fatigue, and true allergic reactions. This clarification helps comfort patients who may be hesitant due to negative past experiences, as pharmacists can explain that these symptoms are actually signs of the immune system responding appropriately.

Beyond administration, pharmacists act as a primary defense against misinformation. Haskell notes that science consistently refutes common myths, such as the idea that vaccines cause the illnesses they prevent or that natural immunity is superior.

By providing simple, direct recommendations and having the important patient conversations in the immunization space, pharmacists contribute significantly to reducing hospitalizations and severe complications across the populations they serve.